ARTICLE | Clinical News
R788: Preliminary Phase I data
February 27, 2006 8:00 AM UTC
Preliminary data from a double-blind, placebo-controlled, U.S. Phase I trial in 16 patients showed that R788 plus methotrexate was well tolerated and caused no significant adverse pharmacokinetic inte...